Experts

ScoPo’s powerplays: Searching for gems as healthcare sector languishes

January 15, 2021January 15, 2021 | Derek Rose

Experts

Trading with Focus – Stereotypes

January 14, 2021January 14, 2021 | Marketech Focus

Experts

MoneyTalks: Morningstar reckons this ASX stock could be a half-price bargain

January 12, 2021 | Nick Sundich

Experts

Pro investors are ‘paying close attention’ to this key 2021 investment theme

January 8, 2021January 8, 2021 | Sam Jacobs

Experts

Money Talks: Here are Barclay Pearce’s top 2021 ASX picks

January 6, 2021January 6, 2021 | Nick Sundich

Experts

Expert view: What will be the best asset class to hold in 2021?

January 5, 2021January 5, 2021 | Peter Farquhar

Experts

Analyst view: Why this fund manager ignores ’80-90 per cent’ of IPOs until they list

January 5, 2021January 5, 2021 | Sam Jacobs

Experts

Expert picks: How to get into the EV boom cycle in 2021

January 4, 2021January 4, 2021 | Peter Farquhar

Experts

Expert view: Which commodities will see strong price rises in 2021?

December 31, 2020December 31, 2020 | Peter Farquhar

Experts

Tim Boreham’s 21 stocks that are primed to run in 2021 – Part II

December 31, 2020 | Tim Boreham

Experts

There’s a strong theme among stocks experts think will benefit from a COVID-19 vaccine in 2021

December 30, 2020December 30, 2020 | Peter Farquhar

Experts

Tim Boreham’s 21 stocks that are primed to run in 2021 – Part I

December 30, 2020December 30, 2020 | Tim Boreham